DAVASAB, NCT01515020: Daptomycin Versus Vancomycin in the Treatment of Nosocomial or Healthcare-associated MRSA Bacteremia |
|
|
| Terminated | 3 | 10 | Europe | vancomycin monotherapy, intravenous therapy, daptomycin monotherapy | Assistance Publique - Hôpitaux de Paris, Novartis | Nosocomial Infection, Healthcare-associated Infection | 06/13 | 07/14 | | |
